Quick Search 
Drugs of Today
Register or sign in

Volume 53, Issue 10, October 2017, Pages 521-568
 Meropenem/vaborbactam fixed combination for the treatment of patients with complicated urinary tract infections.
McCarthy, M.W., Walsh, T.J.
Drugs Today 2017, 53(10): 521
Summary | Full Text: PDF 
 Midostaurin for the treatment of adult patients with newly diagnosed acute myeloid leukemia that is FLT3 mutation-positive.
Garcia, J.S., Percival, M.E.
Drugs Today 2017, 53(10): 531
Summary | Full Text: PDF 
 Sacubitril and valsartan fixed combination to reduce heart failure events in post-acute myocardial infarction patients.
Zaid Iskandar, M., Lang, C.C.
Drugs Today 2017, 53(10): 545
Summary | Full Text: PDF 
 Notable licensing deals in the biopharma industry in the third quarter of 2017.
D'Souza, P.
Drugs Today 2017, 53(10): 553
Summary | Full Text: PDF 
 European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS) – 7th Joint Triennial Congress (October 25-28, 2017 – Paris, France).
Diaz, N.
Drugs Today 2017, 53(10): 559
Summary | Full Text: PDF 
 New product intros (abemaciclib mesylate, delafloxacin meglumine, copanlisib hydrochloride, darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate (new combination), eculizumab (new indication), ibrutinib (new indication), influenza vaccine, quadrivalent, tisagenlecleucel (first-in-class).
Drugs Today 2017, 53(10): 565
Full Text: PDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy